论文部分内容阅读
目的:对阿奇霉素序贯疗法治疗小儿支气管肺炎临床效果进行观察及分析。方法:选取本院2014年7月-2015年7月收治的76例小儿支气管肺炎患儿,并将其随机分为实验组和对照组,分别为38例,实验组采用阿奇霉素序贯疗法对患儿进行治疗;对照组则采用红霉素序贯疗法,对这两组患儿的临床治疗效果进行观察和对比。结果:实验组治愈29例,有效治疗8例,无效1例,总有效率为97.3%。对照组治愈22例,有效治疗11例,无效5例,总有效率为86.84%。两组数据对比实验组的总有效率更高,且实验组患儿的不良反应率比对照组低,数据结果对比差异具有统计学意义(P<0.05)。结论:阿奇霉素序贯法能有效治疗小儿支气管肺炎,并且具有经济、安全、不良反应率低等优势,该方法在临床中具有较高的应用价值。
Objective: To observe and analyze the clinical effect of sequential treatment of azithromycin in children with bronchopneumonia. Methods: A total of 76 children with bronchial pneumonia admitted from July 2014 to July 2015 in our hospital were randomly divided into experimental group and control group, with 38 cases in each group. The experimental group received azithromycin sequential therapy Children were treated; control group is the use of sequential treatment of erythromycin, the clinical efficacy of these two groups of children were observed and compared. Results: In the experimental group, 29 cases were cured, 8 cases were effectively treated and 1 case was ineffective. The total effective rate was 97.3%. Control group, 22 cases were cured, effective treatment in 11 cases, 5 cases, the total effective rate was 86.84%. The two groups of data compared with the experimental group, the total efficiency is higher, and the experimental group of children with adverse reactions than the control group, the data were statistically significant differences (P <0.05). Conclusion: Sequential azithromycin can effectively treat children with bronchopneumonia, and has the advantages of economy, safety and low adverse reaction rate. The method has high value in clinical application.